fda warning letter glp-1 solution september 9 2025 15, 2025: Telehealth company must stop implying its compounded GLP -1 is FDA-approved, warns – Partnership for Safe Medicines Pharmacovigilance analysis of neurological adverse

Adherence is the strongest predictor of success: This applies to any chronic medication, but it's particularly relevant for daily oral dosing

GLP-1 medications represent something genuinely new

Originally developed for type 2 diabetes, GLP-1 receptor agonists, like semaglutide, work by stimulating insulin release, slowing digestion, and signaling fullness in the brain

This suggests our sample was representative of those who could benefit from GLP-1 receptor agonists

A minimal model was used for analyses in which there were insufficient numbers of eligible patients to allow use of the full model (see Exploratory Analyses: Impact of Baseline BMI, Demaglutide Dose, Previous Treatment, Sex and Age)

If your doctor supports you trying a supplement, look for one thats third-party certified, which ensures that the product is labeled accurately and is free of contaminants